Učitavanje...

Secretory Leukocyte Protease Inhibitor Inhibits Infection of Monocytes and Lymphocytes with Human Immunodeficiency Virus Type 1 but Does Not Interfere with Transcytosis of Cell-Associated Virus across Tight Epithelial Barriers

In the present study, we demonstrate that recombinant human secretory leukocyte protease inhibitor (rhSLPI) inhibits infection of lymphocyte- and monocyte-derived tumor cell lines and peripheral blood lymphocytes with laboratory-adapted isolates and with the primary isolate, NDK, of free human immun...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hocini, Hakim, Becquart, Pierre, Bouhlal, Hicham, Adle-Biassette, Homa, Kazatchkine, Michel D., Bélec, Laurent
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2000
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC95905/
https://ncbi.nlm.nih.gov/pubmed/10799472
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!